Suppressed plasma renin activity in hypertension.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000236:Adenoma / Q000175:diagnosis; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000601:surgery; D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine; D000804:Angiotensin II; D000818:Animals; D001681:Biological Assay; D003937:Diagnosis, Differential; D005260:Female; D005665:Furosemide; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis; D006973:Hypertension / Q000175:diagnosis*; D007008:Hypokalemia; D008297:Male; D008875:Middle Aged; D011187:Posture; D011188:Potassium / Q000097:blood; D051381:Rats; D012083:Renin / Q000097:blood*; D012463:Saliva / Q000032:analysis; D012964:Sodium / Q000652:urine; D014882:Water-Electrolyte Balance / Q000187:drug effects
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000804:Angiotensin II; D000450:Aldosterone; D005665:Furosemide; D012964:Sodium; D012083:Renin; D011188:Potassium